8 February, 2010.
Iceland's global generics company Actavis Group is offering some light relief to the country's ongoing economic woes by increasing the capacity of its manufacturing site in Hafnarfjordur by 50%, thus creating fifty new jobs.
Production on the new facility, which exports 95% of its products, is expected to start at the end of this year. After expansion the SOD-site's capacity will be about 1.5 billion tablets per year, depending on the mix of products.
Actavis currently employs around 570 people in Iceland (which has a population of only 320,000) and over 10,000 people worldwide.